10 questions about temozolomide and the treatment of brain tumors.
Pruitt
Amy A
AA
Department of Neurology, University of Pennsylvania, Philadelphia, PA 19104, USA.
Rosenfeld
Myrna R
MR
D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000473:pathology; D003606:Dacarbazine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D000077204:Temozolomide
D018906:Antineoplastic Agents, Alkylating; D003606:Dacarbazine; D000077204:Temozolomide